Article
Longitudinal glioma monitoring via cerebrospinal fluid cell-free DNA: one patient at a time
2024-02-24
Abstract excerpt
<h4>ABSTRACT</h4> <h4>IMPORTANCE</h4> Current methods for glioma treatment response assessment are limited. Intracranial cerebrospinal fluid (CSF) may provide a previously untapped source of longitudinal biomarkers, such as cell-free DNA (cfDNA), for disease monitoring. <h4>OBJECTIVE</h4> To assess the feasibility of obtaining longitudinal intracranial CSF cfDNA from patients with gliomas during their disease cour...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 818fda9d-a5e2-516c-a06f-a451d0a4b342
- DOI
- 10.1101/2024.02.21.24303164
